Rmb Capital Management, LLC Novartis Ag Transaction History

Rmb Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$80.52 - $93.75 $211,687 - $246,468	2,629 New	2,629 $222,000
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $4.64 Million - $5.24 Million	-54,955 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $4.51 Million - $4.97 Million	52,708 Added 2345.71%	54,955 $4.78 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $8,595 - $10,579	-114 Reduced 4.83%	2,247 $206,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $177,830 - $203,400	2,361 New	2,361 $227,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $177,391 - $205,189	-2,650 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $172,011 - $194,404	2,650 New	2,650 $0

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.